A recall of seafood burgers by the Connecticut based company Caraluzzi's Markets has been issued a Class I risk ...

Several current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

Weight-loss drugs like Ozempic and Wegovy are sending dozens of Americans to the hospital every day with potentially ...

From sweet treats to cold medicine, Red Dye No. 3 has been a popular food additive ingredient for decades. Now, it's under scrutiny.

A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...

Experts exploring what other conditions semaglutide, the active ingredient in Wegovy and Ozempic, might help apart from ...

In 2025, AquaSculpt went through one of the largest consumer trials in supplement history. Over 27,000 people participated in ...

Recently, the FDA announced a recall for a certain cat and dog medication due to the presence of “visible particles” in the ...